NERIO THERAPEUTICS, INC.

Profile

Company Names

NERIO THERAPEUTICS, INC.

Addresses

11099 N. TORREY PINES ROAD, STE. 290, LA JOLLA, CA 92037

11099 TORREY PINES PARK ROAD, SUITE 290, LA JOLLA, CA 92037

Phone Numbers

858-750-4700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$6,502,853.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-08-21 
$3,500,003.00 
$10,000,005.00 
$6,500,002.00 
Equity 
1
2020-06-30 
$3,002,850.00 
$5,752,853.00 
$2,750,003.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEFAN 
 
HELLER 
DIRECTOR
JANUX THERAPEUTICS, INC.   |  NERIO THERAPEUTICS, INC.   |  VALORA THERAPEUTICS, INC.
JAY 
 
LICHTER, PH.D. 
DIRECTOR
REVISION THERAPEUTICS, INC.   |  OTONOMY, INC.   |  ARATANA THERAPEUTICS, INC.   |  JANUX THERAPEUTICS, INC.   |  NERIO THERAPEUTICS, INC.   |  ARIALYS THERAPEUTICS, INC.
SANFORD 
J. 
MADIGAN, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
NERIO THERAPEUTICS, INC.
TIGHE 
 
REARDON 
EXECUTIVE OFFICER, DIRECTOR
AVALON VENTURES XI, L.P.   |  ARISTAMD, INC.   |  SYNTHORX, INC.   |  CELLULAR APPROACHES, INC.   |  JANUX THERAPEUTICS, INC.   |  NERIO THERAPEUTICS, INC.   |  ANKASA REGENERATIVE THERAPEUTICS, INC.   |  AVALON BIOVENTURES SPV I, L.P.   |  ENLAZA THERAPEUTICS, INC.   |  AVALON BIOVENTURES SPV II, L.P.   |  ARIALYS THERAPEUTICS, INC.   |  AERORX THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-10-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-21 
2020-07-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#